Literature DB >> 8907568

Heterogeneity of hepatitis B virus (HBV) core gene in a patient with HBV-associated cirrhosis and serum negativity for anti-HBc.

F Zoulim1, X Zhang, C Pichoud, C Trepo.   

Abstract

AIMS: We describe here the case of a patient suffering from severe chronic hepatitis B associated with an unusual hepatitis B virus serology: HBsAg and HBeAg were both positive while anti-HBc was negative by radioimmunoassay.
METHODS: A very sensitive anti-HBc ELISA (IMx CORE) was performed and was able to detect anti-HBc sporadically throughout the clinical course. Molecular characterization of hepatitis B virus strains in this patient enabled us to explain this particular serological and clinical pattern of hepatitis B virus infection.
RESULTS: Hepatitis B virus genotype determined by size polymorphism of the core gene and the pre-S region was found to be D/E and consistent with the results of serological subtyping (HBV ayw2-4). DNA sequence analysis of the pre-C/C region showed the presence of significant nucleotide changes. In association with a wild type hepatitis B virus strain, we could detect at least four hepatitis B virus variants with nucleotide deletions leading to a frameshift in the core gene. According to the position of the mutations, these hepatitis B virus core variants are expected to be defective for B-cell epitopes and TH-cell epitopes.
CONCLUSIONS: These mutations explain the low level production of anti-HBc antibody. It is noteworthy that the absence of detectable anti-HBc in serum was associated with severe liver damage, suggesting that the deficient humoral response to HBcAg was not accompanied by a cellular immune tolerance to HBc/eAg, the supposed target for cytotoxic T-cell lysis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8907568     DOI: 10.1016/s0168-8278(96)80024-9

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  6 in total

Review 1.  The underlying mechanisms for the "isolated positivity for the hepatitis B surface antigen (HBsAg)" serological profile.

Authors:  Robério Amorim de Almeida Pondé
Journal:  Med Microbiol Immunol       Date:  2010-05-11       Impact factor: 3.402

2.  Immune suppression as the etiology of failure to detect anti-HBc antibodies in patients with chronic hepatitis B virus infection.

Authors:  V Avettand-Fenoel; D Thabut; C Katlama; T Poynard; V Thibault
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

Review 3.  New strategies for blood donor screening for hepatitis B virus: nucleic acid testing versus immunoassay methods.

Authors:  Mary C Kuhns; Michael P Busch
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

4.  Microarray for hepatitis B virus genotyping and detection of 994 mutations along the genome.

Authors:  Marie Gauthier; Bertrand Bonnaud; Maud Arsac; Fabien Lavocat; Jérôme Maisetti; Alan Kay; François Simon; Fabien Zoulim; Guy Vernet
Journal:  J Clin Microbiol       Date:  2010-09-08       Impact factor: 5.948

Review 5.  Atypical serological profiles in hepatitis B virus infection.

Authors:  Robério A A Pondé
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-11-29       Impact factor: 3.267

6.  Acute hepatitis B virus infection with delayed appearance of hepatitis B core antibody in an immunocompromised patient: a case report.

Authors:  Nicholas Brousseau; Donald G Murphy; Vladimir Gilca; Jacynthe Larouche; Sema Mandal; Richard S Tedder
Journal:  J Med Case Rep       Date:  2017-04-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.